Non-steroidal topical composition and method thereof

The embodiments relate to a non-steroidal topical formulation comprising 10 wt% 5 to 20 wt% of an active ingredient consisting of a combination of group I and group II component and 80 wt% to 90 wt% of inactive ingredient comprising one or more pharmaceutically acceptable excipient. The group I component maybe a plant extract obtained from Curcuma spp, Litsea spp., and Lepidium spp. and group II component may be selected from a group comprising Potassium sulfate 10 (Kali sulphuricum), Potassium Phosphate (Kali phosphoricum), Sodium sulfate (Natrum sulphuricum, Sodium chloride (Natrum muriaticum), Potassium Chloride (Kali muriaticum), and Sodium Phosphate (Natrum phosphoricum).The said formulation is capable of efficiently eliminating or reducing age-related osteoarthritic joint pain, inflammation and musculoskeletal diseases and provides 15 long-term relief to the aged patients. Another preferred embodiment of the present invention relates to a method of preparing the said formulation..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 23. Feb. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

GUPTA ANUPAM [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
C11D: Detergent compositions; use of single substances as (...)
cet
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-02-23, Last update posted on www.tib.eu: 2024-03-04, Last updated: 2024-03-08

Patentnummer:

AU2021449881

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA016925416